Adam is a Senior Global Payer Strategy Manager working in oncology pipeline at Boehringer Ingelheim. He is managing global pricing and market access strategies for the oncology portfolio and driving the development of innovative market access approaches and payment schemes. Since September 2015 he is also heading the Boehringer Ingelheim Pricing Team working across the whole Boehringer Ingelheim prescription medicines portfolio.
Prior to joining Boehringer Ingelheim Adam worked as a life sciences strategy consultant for IMS Consulting, Truven Analytics and Simon-Kucher & Partners in Belgium, France, Germany, Poland, Romania and The United States. He also worked as a research assistant at Jules Gonin Eye Hospital in Lausanne, Switzerland and as a Junior Project Leader at AnalyCen in Poland and Sweden.
Adam holds a M.Sc. in Molecular Biology and Biotechnology from University of Warsaw, Poland, and a Ph.D. in Neurosciences from University of Geneva, University of Lausanne and EPFL, Switzerland. He has published several articles in international peer reviewed journals, and lectured at international conferences on developmental